Evofem Biosciences, Inc.
EVFM
$0.01
$0.00-5.26%
OTC PK
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 471.01% | -88.11% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 471.01% | -88.11% | |||
| Cost of Revenue | 106.85% | -75.86% | |||
| Gross Profit | 747.92% | -91.42% | |||
| SG&A Expenses | -10.01% | -55.88% | |||
| Depreciation & Amortization | -52.02% | -29.87% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1,072.97% | -93.61% | |||
| Operating Income | -482.57% | 132.60% | |||
| Income Before Tax | -285.88% | 131.48% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -286.61% | 131.48% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -286.61% | 131.48% | |||
| EBIT | -482.57% | 132.60% | |||
| EBITDA | -305.04% | 181.76% | |||
| EPS Basic | -283.33% | 129.17% | |||
| Normalized Basic EPS | -281.13% | 129.61% | |||
| EPS Diluted | -10,100.00% | 100.66% | |||
| Normalized Diluted EPS | -9,700.00% | 100.56% | |||
| Average Basic Shares Outstanding | 2.06% | 7.16% | |||
| Average Diluted Shares Outstanding | -98.08% | 5,609.55% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||